Myrcia para Diabetes y control glucémico
Myrcia bella — 6 estudios científicos revisados
Moderate¿Sirve Myrcia para diabetes y control glucémico?
Uso documentado en la medicina tradicional y respaldado por investigación preliminar
Compuestos activos involucrados:
Evidencia Científica
Los siguientes estudios han investigado la relación entre Myrcia y diabetes y control glucémico:
Myrcia bella Leaf Extract Presents Hypoglycemic Activity via PI3k/Akt Insulin Signaling Pathway.
Species of Myrcia are used by indigenous people and in traditional communities in Brazil for the treatment of Diabetes mellitus. We investigated the hypoglycemic effect of the extract of leaves of Myrcia bella in diabetic mice. The chemical fingerprinting of the 70% EtOH extract characterized as main constituents flavonoid aglycones, flavonoid-O-glycosides, and acylated flavonoid-O-glycosides derivatives of quercetin and myricetin. Mice were treated with saline or extract of M. bella (300 or 600 mg/Kg b.w.) for 14 days.
PubMed: 24872834Characterization of flavonoids and phenolic acids in Myrcia bella Cambess. using FIA-ESI-IT-MS(n) and HPLC-PAD-ESI-IT-MS combined with NMR.
The leaves of Myrcia DC. ex Guill species are used in traditional medicine and are also exploited commercially as herbal drugs for the treatment of diabetes mellitus. The present work aimed to assess the qualitative and quantitative profiles of M. bella hydroalcoholic extract, due to these uses, since the existing legislation in Brazil determines that a standard method must be developed in order to be used for quality control of raw plant materials. The current study identified eleven known flavonoid-O-glycosides and six acylated flavonoid derivatives of myricetin and quercetin, together with
PubMed: 23863778Metabolomics of
Environmental conditions influence specialized plant metabolism. However, many studies aiming to understand these modulations have been conducted with model plants and/or under controlled conditions, thus not reflecting the complex interaction between plants and environment. To fully grasp these interactions, we investigated the specialized metabolism and genetic diversity of a native plant in its natural environment. We chose
PubMed: 32604974Antimutagenicity and induction of antioxidant defense by flavonoid rich extract of Myrcia bella Cambess. in normal and tumor gastric cells.
ETHNOPHARMACOLOGICAL RELEVANCE: The Brazilian "Cerrado" is an important source of natural products, such as Myrcia bella Cambess (MB, also known as "mercurinho"). MB leaves are popularly used for the treatment of diabetes and gastrointestinal disorders; however, only its hypoglycemic activity has been experimentally described. AIM OF THE STUDY: Because MB is used to treat gastrointestinal disorders, the present study characterized biological activities of hydroalcoholic MB extract in human normal and tumor gastric cells. MATERIALS AND METHODS: Cytotoxic, antiproliferative, genotoxic and protec
PubMed: 26549270The Effect of Solutions Containing Extracts of Vochysia tucanorum Mart., Myrcia bellaCambess., Matricaria chamomilla L. and Malva sylvestris L. on Cariogenic Bacterial Species and Enamel Caries Development.
This study evaluated the effect of experimental solutions containing plant extracts on bacterial species and enamel caries prevention. Microcosm biofilm was produced from human saliva mixed with McBain saliva (0.2% sucrose) on bovine enamel for 5 days (3 days under anaerobiosis and 2 days under aerobiosis) at 37°C. From the 2nd day, the following treatments were applied (1 × 60 s/day): Vochysia tucanorum (10 mg/mL); Myrcia bella (5 mg/mL); Matricaria chamomilla (80 mg/mL); Malva sylvestris, fluoride, and xylitol (Malvatricin Plus®); 0.12% chlorhexidine (CHX, PerioGard®); and PBS (negative cont
PubMed: 34000728Seguridad y Precauciones
El uso de Myrcia bella (conocida popularmente en el Cerrado brasileño como 'mercurinho') requiere una precaución extrema debido a su potente actividad biológica, especialmente su efecto hipoglucemiante. En el caso de mujeres embarazadas o en periodo de lactancia, no existe evidencia científica que garantice la seguridad del consumo de extractos de Myrcia bella en estos estados fisiológicos. Dado que la planta interactúa con las vías de señalización de la insulina (PI3k/Akt), existe un riesgo teórico de que los compuestos puedan atravesar la barrera placentaria o pasar a la leche materna, afectando el metabolismo glucémico del feto o del lactante. Debido a la falta de estudios de toxicidad reproductiva, su uso está contraindicado en estas poblaciones. Para niños menores de 12 años, el uso debe evitarse estrictamente. Los sistemas metabólicos en desarrollo son altamente sensibles a las fluctuaciones de glucosa y a los compuestos fenólicos; la administración de dosis no estandarizadas podría provocar hipoglucemia severa en infantes, cuya regulación glucémica es distinta a la de los adultos.
Otras plantas estudiadas para Diabetes y control glucémico
Perfil completo: Ver todos los usos y evidencia de Myrcia →